Cargando…
Optical Coherence Tomography: Is Really a New Biomarker for Alzheimer's Disease?
INTRODUCTION: Retinal ganglion cell (RGC) degeneration was histopathologically proved previously in Alzheimer's disease (AD) patients. In this study, we aimed to determine RGC degeneration in vivo using optical coherence tomography (OCT) in AD. METHODS: Twenty-one mild-to-moderate AD patients a...
Autores principales: | Poroy, Ceren, Yücel, Ahmet Âli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073964/ https://www.ncbi.nlm.nih.gov/pubmed/30122836 http://dx.doi.org/10.4103/aian.AIAN_368_17 |
Ejemplares similares
-
The role of optical coherence tomography in Alzheimer’s disease
por: Cunha, Leonardo Provetti, et al.
Publicado: (2016) -
Optical coherence tomography angiography in preclinical Alzheimer’s disease
por: van de Kreeke, Jacoba Alida, et al.
Publicado: (2020) -
Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Doustar, Jonah, et al.
Publicado: (2017) -
Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis
por: Coppola, Gianluca, et al.
Publicado: (2015) -
Evaluation of choroidal thickness in children with type 1 diabetes: the role
of optical coherence tomography in diabetic retinopathy screening
por: Ermerak, Basak Can, et al.
Publicado: (2021)